BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25676571)

  • 1. [Forward].
    Freund M; Lüftner D; Wilhelm M
    Oncol Res Treat; 2015; 38 Suppl 1():1. PubMed ID: 25676571
    [No Abstract]   [Full Text] [Related]  

  • 2. [Workshop - economic governance mechanisms : for Hematology and Oncology].
    Strech D; Deh U; Schmitz S; Gürkan I; Ostermann H; Krause SW
    Oncol Res Treat; 2015; 38 Suppl 1():3-22. PubMed ID: 25676572
    [No Abstract]   [Full Text] [Related]  

  • 3. [View].
    Freund M; Lüftner D; Wilhelm M
    Oncol Res Treat; 2015; 38 Suppl 1():23. PubMed ID: 25676573
    [No Abstract]   [Full Text] [Related]  

  • 4. [Economy and medicine in haematology and oncology].
    Krych M; Ostermann H
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2115-8. PubMed ID: 18985566
    [No Abstract]   [Full Text] [Related]  

  • 5. The unit costs of inpatient hospital days, outpatient visits, and daycare treatments in the fields of oncology and hematology.
    Tan SS; Van Gils CW; Franken MG; Hakkaart-van Roijen L; Uyl-de Groot CA
    Value Health; 2010; 13(6):712-9. PubMed ID: 20561330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of Medicaid on research-based care in pediatric hematology/oncology.
    van Eys J
    Am J Pediatr Hematol Oncol; 1991; 13(1):91-6. PubMed ID: 2029085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis-related groups as an instrument to develop suitable case-based lump sums in hematology and oncology].
    Thalheimer M
    Onkologie; 2011; 34 Suppl 1():11-5. PubMed ID: 21389763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Rationalization, rationing, prioritization: terminology and ethical approaches to the allocation of limited resources in hematology/oncology].
    Winkler E
    Onkologie; 2011; 34 Suppl 1():2-5. PubMed ID: 21389761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benefit-risk evaluation of new drugs as a basis for decisions on prioritization in hematology/oncology: methodical challenges and problem-solving strategies].
    Ludwig WD; Schildmann J
    Onkologie; 2011; 34 Suppl 1():6-10. PubMed ID: 21389762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interest in and limitations of economic assessment applied to the evaluation of medical strategies: examples in oncological hematology].
    Moatti JP
    Therapie; 2001; 56(2):135-8. PubMed ID: 11471364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of self-adapting G-DRG system 2004 to 2006 on in-patient services payment in pediatric hematology and oncology patients of a university hospital].
    Christaras A; Schaper J; Strelow H; Laws HJ; Göbel U
    Klin Padiatr; 2006; 218(6):366-78. PubMed ID: 17080340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction to the Symposium on Neoplastic Hematology and Medical Oncology.
    Rajkumar SV; Kohli M
    Mayo Clin Proc; 2015 Jul; 90(7):848-9. PubMed ID: 26141326
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oncology caught between economics and efficiency].
    Keil TU
    Med Klin (Munich); 2000 Jun; 95 Suppl 1():1. PubMed ID: 10941245
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluation in radiology: reviewing the literature and examples in oncology.
    Bresnahan BW
    Acad Radiol; 2010 Sep; 17(9):1090-5. PubMed ID: 20634104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affordable oncologic care: a challenging goal.
    Barton MK
    CA Cancer J Clin; 2014; 64(2):75-8. PubMed ID: 24420975
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing oncology costs.
    Reeder CE; Gordon D
    Am J Manag Care; 2006 Feb; 12(1 Suppl):S3-16; quiz S17-9. PubMed ID: 16478368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The real CER: lost in translation.
    Pearson S
    Oncology (Williston Park); 2011 Apr; 25(4):320, 323. PubMed ID: 21618953
    [No Abstract]   [Full Text] [Related]  

  • 18. Stopping the drain of dollars spent on breast cancer.
    Kneece J
    Adm Radiol; 1994 Jun; 13(6):27-9. PubMed ID: 10136526
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
    J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
    [No Abstract]   [Full Text] [Related]  

  • 20. StatBite: Survey: Oncologists on Costs and Treatment.
    J Natl Cancer Inst; 2009 Nov; 101(21):1443. PubMed ID: 19828872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.